Shanda Asset Management Holdings LTD Laboratory Corp Of America Holdings Transaction History

Shanda Asset Management Holdings LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $675,532 - $775,268	-2,600 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $354,792 - $398,066	-1,291 Reduced 33.18%	2,600 $732,000
Q1 2020 May 15, 2020	BUY	$104.32 - $195.28 $164,095 - $307,175	1,573 Added 67.86%	3,891 $492,000
Q1 2019 May 15, 2019	SELL	$123.7 - $156.3 $286,736 - $362,303	-2,318 Reduced 50.0%	2,318 $355,000
Q4 2018 Feb 14, 2019	BUY	$120.82 - $174.09 $560,121 - $807,081	4,636 New	4,636 $586,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.